Potential Medical Uses of Cannabigerol: A Brief Overview
January 2017
in “
Elsevier eBooks
”
Studysummary This review explores cannabigerol (CBG) as a potential therapeutic agent with various pharmacological activities but reports no new clinical results, emphasizing the need for further research on its efficacy and safety. Our plain-language summary of this paper — not a Tressless recommendation.
The document from 2017 reviews the potential medical applications of cannabigerol (CBG), a non-psychotropic cannabinoid from the cannabis plant. CBG has shown anti-inflammatory, analgesic, and antiproliferative properties, which may be beneficial in treating conditions such as mood disorders, skin diseases, glaucoma, hormonal dysregulations, eating disorders, and bone healing. It has demonstrated effectiveness in reducing pain in mice, protecting against colitis in a murine model, and exhibiting neuroprotective actions in models of multiple sclerosis. Additionally, CBG has potential in treating prostate cancer, androgenic alopecia, psoriasis, and osteoporosis, and has shown antibacterial activity against MRSA. However, further research is needed to confirm its clinical efficacy and safety in humans, as studies on CBG's pharmacokinetics and pharmacodynamics in humans were lacking at the time of publication.
